Investors who purchased Genesis HealthCare five years ago have seen their shares in the company fall by 82% during that time, according to an analysis posted Wednesday by Simply Wall St. The company’s share price decline has continued over the last week, dropping some 26%.
The analysts go on to discuss how Genesis saw its revenue shrink by 0.6% per year — generally not what investors like to see, they noted.
“When a company doesn’t make profits, we’d generally expect to see good revenue growth,” the analysts said. “That’s because it’s hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.”
Genesis also announced Wednesday that the company was pushing the release of its fourth-quarter and year-end 2019 earnings results until after the market closes on Monday. The results originally were scheduled to be released Thursday.
